The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF
therapy is more effective than treatment with anti-TNF therapy alone in inducing and
maintaining steroid-free remission for children with Crohn's Disease.
Phase:
Phase 3
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborators:
Children's Hospital Medical Center, Cincinnati Grifols Diagnostics Solutions, Inc ImproveCareNow (ICN) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institutes of Health (NIH) Patient-Centered Outcomes Research Institute The Leona M. and Harry B. Helmsley Charitable Trust
Treatments:
Folic Acid Methotrexate Ondansetron Vitamin B Complex